TANFAC Industries Secures BSE Approval for Preferential Equity Issue

Issue Size: 4,24,647 Equity Shares
Issue Price: Rs 2,341 per share

Reader Takeaway: The approval clears a key regulatory hurdle for capital infusion, though investors should monitor dilution and compliance adherence.

What just happened

TANFAC Industries Ltd has received in-principle approval from BSE Limited for the issuance of 4,24,647 equity shares via a preferential route. The approval, granted on August 31, 2026, pertains to shares priced at Rs 2,341 each, to be allotted to a mix of promoter and non-promoter investors.

Why this matters

This approval is a critical step in the company’s capital-raising exercise. By clearing this stage, TANFAC Industries can now finalize the allotment process, effectively strengthening its balance sheet. The move signals the company's intent to expand its equity base to support future corporate objectives.

Regulatory and Compliance Requirements

The BSE has mandated strict adherence to the Companies Act 2013 and SEBI regulations. Key compliance points include:

• Strengthening internal controls to monitor allottee trades.
• Obtaining undertakings from allottees to restrict intra-day trading or sales until the allotment is fully processed.
• Rigorous verification of compliance with Regulation 167(6) of the SEBI ICDR regulations.
• Compulsory submission of listing applications within 20 days post-allotment.

What to track next

Investors should look for the forthcoming company filing confirming the successful completion of the allotment. Following this, the company must initiate the listing process on the exchange, which will be the final step in the capital infusion timeline.